The Barricaid bone-anchored implant is the first device clinically proven to reduce the incidence of reherniation and reoperation in patients with large annular defects.
Clinical studies show that Barricaid patients benefit from significantly reduced disc reherniations and reoperations – and the associated debilitating pain.
To reduce needless suffering by ensuring Barricaid is accessible to patients and surgeons
We work to create a world where lumbar herniation doesn’t define lives.
For two decades, we worked with world-renowned surgeons, scientists, clinical investigators, and medical advisors to develop the Barricaid solution for patients at high risk for reherniation.